Abstract

Epidemiology and clinical course of late onset inflammatory bowel disease

Minerva Gastroenterol (Torino). 2021 May 31. doi: 10.23736/S2724-5985.21.02890-4.Online ahead of print.

Anna Viola 1, Gionata Fiorino 2, Giuseppe Costantino 3, Walter Fries 3

 
     

Author information

  • 1Gastroenterology and Clinical Unit for Chronic Bowel Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy - annaviola88@gmail.com.
  • 2IBD Centre, Department of Gastroenterology, Humanitas Research Hospital, Rozzano, Milan, Italy.
  • 3Gastroenterology and Clinical Unit for Chronic Bowel Disorders, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Abstract

With the increasing age of the general population in developed countries, the management of several chronic diseases becomes more and more complex due to comorbidities. Some, especially inflammatory bowel diseases, formerly believed to belong to the young adult population, have now been recognized as being present at disease onset also in the ageing population, representing medical challenges different from those in the younger population. In the past years, knowledge on this special older population has increased, changing initial beliefs concerning epidemiology and course of disease. In the present review, we will address the most recent evidence concerning their current incidence compared with other age groups, their clinical course, potential risk factors for the development of late-onset IBDs, associated diseases, and cancer risk beyond therapy-related neoplasias.

© Copyright 2013-2022 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.